New 3D model sheds light on beta-amyloid effect

Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have presented a groundbreaking study that sheds light on the complex mechanisms underlying Alzheimer’s disease (AD). The study, titled “Effects of amyloid-β-mimicking peptide hydrogel matrix on neuronal progenitor cell phenotype,” represents a major leap forward in understanding the interaction between amyloid-like structures and neuronal cells.

Led by Natashya Falcone and first authors Tess Grett Mathes and Mahsa Monirizad, the research team delved into the realm of self-assembling peptide-based hydrogels, known for their versatility in mimicking extracellular matrices (ECM) of different microenvironments.

AD presents a complex challenge to neurodegenerative research. Traditional two-dimensional (2D) models have limitations in capturing the complexity of disease. Through their innovative approach, the team developed a multicomponent hydrogel scaffold, called Col-HAMA-FF, designed to mimic the amyloid-beta (β)-containing microenvironment associated with AD.

The study’s findings, published in a recent issue of Acta Biomaterialia, illuminate the formation of β-sheet structures within the hydrogel matrix, mimicking the nanostructures of amyloid-β proteins. By growing healthy neural progenitor cells (NPCs) in this amyloid-mimicking environment and comparing the results to those in a native-mimicking matrix, the researchers observed high levels of markers of neuroinflammation and apoptosis. This suggests an important effect of amyloid-like structures on NPC phenotypes and behaviors.

This seminal work provides a promising scaffold for future research on AD mechanisms and drug trials. By bridging the gap between 3D hydrogel models and the complex reality of AD pathological nanostructures, we aim to understand this interaction in healthy neuronal cells so that we can accelerate the development of effective therapeutic strategies.”

Dr. Ali Khademhosseini, Terasaki Institute for Biomedical Innovation

The study represents a critical step toward unraveling the mysteries of the β-amyloid-like environment that can be found in AD and marks a milestone in the search for innovative solutions to combat neurodegenerative disorders.